Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
CHOLECALCIFEROL
HYPHENS PHARMA PTE. LTD.
A11CC05
SOLUTION
CHOLECALCIFEROL 25000IU
ORAL
Prescription Only
SMB Technology S.A.
ACTIVE
2017-06-05
1. NAME OF THE MEDICINAL PRODUCT Cholecalciferol (D-Cure) 25,000 IU oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution (1 single-dose oral solution in ampoule) contains 0.625 mg cholecalciferol, equivalent to 25,000 IU vitamin D. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution Clear, slightly yellow, oily liquid with an orange odour 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Indicated for the prevention and treatment of vitamin D deficiency. As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Paediatrics: - Prevention of deficiency 0-1 years 25000 IU (1 single-dose oral solution in ampoule) every 8 weeks - Prevention of deficiency 1-18 years 25000 IU (1 single-dose oral solution in ampoule) every 6 weeks -Treatment of deficiency 0-18 years 25000 IU (1 single-dose oral solution in ampoule) once every 2 weeks for 6 weeks (followed by maintenance therapy of 400-1000 IU/day) _Administration to children: _ In children, Cholecalciferol (D-Cure) can be mixed with a small amount of children's foods, yogurt, milk, cheese or other dairy products. The parents should be warned not to mix Cholecalciferol (D-Cure) into a bottle of milk or container of soft foods in case the child does not consume the whole portion, and does not receive the full dose. The parents should ensure that their child takes the entire dose. For children who are not breast-feeding, the prescribed dose should be administered with a meal. Adults: - Prevention of vitamin D deficiency 25000 IU/month (1 single-dose oral solution in ampoule) - Treatment of vitamin D deficiency (<25 ng/ml) 50000 IU/week (2 single-dose oral solution in ampoule) for 6-8 weeks, followed by maintenance therapy (1400-2000 IU/day may be required; follow-up 25(OH)D measurements should be made approximately three to four months after initiating maintenance therapy to confirm that the target level has be Read the complete document